On the mechanism of CD47 targeting in cancer.
作者信息
Zhao Xi Wen, Matlung Hanke L, Kuijpers Taco W, van den Berg Timo K
出版信息
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2843; author reply E2844-5. doi: 10.1073/pnas.1209265109. Epub 2012 Aug 24.
Abstract
摘要
相似文献
1
On the mechanism of CD47 targeting in cancer.
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2843; author reply E2844-5. doi: 10.1073/pnas.1209265109. Epub 2012 Aug 24.
2
Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies.
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):E2842; author reply E2844-5. doi: 10.1073/pnas.1205441109. Epub 2012 Aug 24.
3
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.
4
SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
Trends Immunol. 2018 Mar;39(3):173-184. doi: 10.1016/j.it.2017.12.005. Epub 2018 Jan 11.
5
The CD47-SIRPα Immune Checkpoint.
Immunity. 2020 May 19;52(5):742-752. doi: 10.1016/j.immuni.2020.04.011.
6
The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
Immunol Rev. 2017 Mar;276(1):145-164. doi: 10.1111/imr.12527.
7
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis.
Front Immunol. 2020 Jan 28;11:18. doi: 10.3389/fimmu.2020.00018. eCollection 2020.
8
Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis.
Cell Res. 2019 Jun;29(6):502-505. doi: 10.1038/s41422-019-0177-0. Epub 2019 May 14.
9
Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Thyroid. 2019 Jul;29(7):979-992. doi: 10.1089/thy.2018.0555. Epub 2019 May 10.
10
CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
J Immunol Res. 2018 Nov 7;2018:6156757. doi: 10.1155/2018/6156757. eCollection 2018.
引用本文的文献
1
CD47-a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features.
World J Surg Oncol. 2024 Feb 6;22(1):44. doi: 10.1186/s12957-024-03308-6.
2
The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions.
Cancer Cell. 2023 Dec 11;41(12):2051-2065.e6. doi: 10.1016/j.ccell.2023.10.007. Epub 2023 Nov 16.
3
The Antitumor Activities of Anti-CD47 Antibodies Require Fc-FcγR interactions.
bioRxiv. 2023 Jun 29:2023.06.29.547082. doi: 10.1101/2023.06.29.547082.
4
Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer.
Cancer Control. 2023 Jan-Dec;30:10732748231159706. doi: 10.1177/10732748231159706.
5
CD47 as a promising therapeutic target in oncology.
Front Immunol. 2022 Aug 22;13:757480. doi: 10.3389/fimmu.2022.757480. eCollection 2022.
6
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils.
Cancers (Basel). 2022 Jul 11;14(14):3366. doi: 10.3390/cancers14143366.
7
Insights into CD47/SIRPα axis-targeting tumor immunotherapy.
Antib Ther. 2018 Aug 28;1(2):37-42. doi: 10.1093/abt/tby006. eCollection 2018 Sep.
8
Functions of Thrombospondin-1 in the Tumor Microenvironment.
Int J Mol Sci. 2021 Apr 27;22(9):4570. doi: 10.3390/ijms22094570.
9
Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.
PLoS One. 2016 Apr 19;11(4):e0153550. doi: 10.1371/journal.pone.0153550. eCollection 2016.
10
Original insights on thrombospondin-1-related antireceptor strategies in cancer.
Front Pharmacol. 2015 Oct 29;6:252. doi: 10.3389/fphar.2015.00252. eCollection 2015.
本文引用的文献
1
Is targeting of CD47-SIRPα enough for treating hematopoietic malignancy?
Blood. 2012 May 3;119(18):4333-4; author reply 4334-5. doi: 10.1182/blood-2011-11-391367.
2
The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors.
Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6662-7. doi: 10.1073/pnas.1121623109. Epub 2012 Mar 26.
3
CD47-signal regulatory protein-α (SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction.
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18342-7. doi: 10.1073/pnas.1106550108. Epub 2011 Oct 31.
4
CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation.
J Biol Chem. 2000 Dec 1;275(48):37984-92. doi: 10.1074/jbc.M002334200.
5
Integrin-associated protein is a ligand for the P84 neural adhesion molecule.
J Biol Chem. 1999 Jan 8;274(2):559-62. doi: 10.1074/jbc.274.2.559.
Zotero 插件